Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT07032844
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- Digital Health Coaching — BEHAVIORALThis program will be developed using existing, evidence-based curricula for chronic disease self-management. Prior to initiating health coaching with participants, coaches will review data collected related to SDoH to further tailor the intervention as appropriate for housing stability, access to food and transportation, and interpersonal safety. All coaches will have access to participants' EMRs such that they can view medical information throughout the intervention. Coaches will be trained using a curriculum developed by Family and Community Medicine's inter-professional care team and our partners at NCHPAD, making the coaching inclusive of people with physical disabilities, such that the coaches are proficient in motivating behavior change related to resilience, physical activity, nutrition, mindfulness, and relationship-building, among others.
- Continuous Glucose Monitoring Teleconsults — BEHAVIORALThis comparator arm consists of continuous glucose monitoring (CGM) with periodic teleconsult visits over 6 months, delivered by trained pharmacists, RDs, or nurses, with devices shipped centrally to participants' homes. Sensors are replaced per manufacturer guidelines. During onboarding, participants receive device education and standardized safety counseling on recognizing and managing hypoglycemia (\<70 mg/dL; severe \<54 mg/dL) and hyperglycemia (\>300 mg/dL), including when to seek urgent or emergency care. During each teleconsult, the CGM team reviews Time in Range, Time Above Range, and Time Below Range, identifies patterns between glucose and lifestyle factors, and supports goal setting and medication adjustments as needed. Participants with repeated missed readings are contacted by the study team to troubleshoot adherence barriers.
- Continuous Glucose Monitoring Teleconsults + Digital Health Coaching — BEHAVIORALIn this arm, participants receive an integrated approach to diabetes management combining both digital health coaching and CGM-teleconsults, added in response to stakeholder and reviewer feedback expressing interest in benefiting from both interventions. Health coaches and CGM-trained team members work collaboratively to help participants set realistic goals and reinforce lifestyle strategies: the health coach evaluates the participant's food choices in relation to blood sugar patterns, while the CGM team reinforces the nutrition and physical activity recommendations set by the health coach during CGM teleconsults. Information flows bidirectionally - the CGM team informs the health coach of areas needing more emphasis, and the health coach flags participants who may need closer monitoring - so that each participant's care remains cohesive and adaptive to their glucose data and behavioral progress together.
Study Details
The purpose of the study is to compare 2 primary care based telehealth interventions- 1) digital health coaching and 2) remote patient monitoring for improving glycemic (blood sugar levels) control and overall health outcomes in individuals with physical disabilities, type 2 diabetes (T2DM) and at least one chronic condition. The project aims to determine which intervention is more effective in reducing blood sugar levels, improving patient-reported outcomes such as diabetes-related distress, and facilitating the implementation of these approaches in real-world primary care settings serving vulnerable populations. The findings intend to inform about optimal telehealth strategies for managing multiple chronic conditions in underserved groups, there by supporting improved health equity and quality of care.
Key Dates
- First listed
- Jun 24, 2025
- Start date
- Sep 15, 2026
- Status verified
- Jul 2026
- Primary completion
- Dec 1, 2027
- Completion
- Jan 31, 2028
Study Design
- Enrollment
- 5,000 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Digital Health CoachingParticipants receive individual digital health coaching by phone: weekly calls for the first 12 weeks addressing goal setting, supportive environments for behavior change, physical activity, and nutrition, followed by biweekly calls for an additional 12 weeks (weeks 13-24) to reinforce habits and advance goals.
- Experimental: Continuous Glucose Monitoring TeleconsultsParticipants receive continuous glucose monitoring (CGM) with periodic clinician teleconsults over 6 months. Study staff ship a CGM kit (sensor and reader, for participants without a compatible smartphone) to the participant's home; sensors are replaced per manufacturer guidelines. During onboarding, participants receive device education and safety counseling on recognizing and managing hypoglycemia (\<70 mg/dL; severe \<54 mg/dL) and hyperglycemia (\>300 mg/dL). During each teleconsult, the primary care team reviews Time in Range, Time Above Range, and Time Below Range, identifies patterns between glucose and lifestyle factors, and adjusts goals or medications as needed.
- Experimental: Combination of Digital Health Coaching and CGM-TeleconsultsParticipants receive both digital health coaching and CGM-teleconsults in an integrated approach.
Primary Outcome Measure
Change in Hemoglobin A1c [ Time Frame: 12 months ]
Central Contacts
- Aseel El Zein, PhD205-201-1507
- Rebecca Rogers, MS(205) 975-5221
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UAB Highlands Hospital/Department of Family and Community Medicine | Birmingham | Alabama | 35223 |
Find similar trials in Birmingham, AL
Related Studies
- AI Ready and Exploratory Atlas for Diabetes InsightsEnrolling By Invitation · University of Washington · Birmingham, Alabama
- MObile Support Adapted to Individual ContextsEnrolling By Invitation · Vanderbilt University Medical Center · Birmingham, Alabama
- A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric PatientsRecruiting · University of Alabama at Birmingham · Birmingham, Alabama
- Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based TherapyPHASE2 · Recruiting · Biomea Fusion Inc. · Birmingham, Alabama